GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » Assura PLC (OTCPK:ARSSF) » Definitions » Capital Expenditure

ARSSF (Assura) Capital Expenditure : $-87.13 Mil (TTM As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Assura Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Assura's cash flow for capital expenditures for the six months ended in Mar. 2024 was $-47.8 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2024 was $-87.13 Mil.


Assura Capital Expenditure Historical Data

The historical data trend for Assura's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Assura Capital Expenditure Chart

Assura Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -66.71 -78.92 -83.93 -70.27 -88.18

Assura Semi-Annual Data
Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -46.90 -32.05 -35.92 -39.36 -47.78

Assura Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-87.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Assura Business Description

Traded in Other Exchanges
Address
3 Barrington Road, Altrincham, GBR, WA14 1GY
Assura PLC is a healthcare facility REIT. The company operates one segment that develops, owns, and manages primary-care properties. All the company's revenue is generated in the United Kingdom. Assura seeks properties that are characterized by a secure and predictable income stream with an underpinning of inflation linkage. The company considers merger and acquisition investment to be a component of its operational growth strategy. It engages in relationship-building with general practitioners to secure investment opportunities.

Assura Headlines

From GuruFocus

Q1 2021 Assura PLC Trading Statement Call Transcript

By GuruFocus Research 02-12-2024

Assura PLC Annual Shareholders Meeting Transcript

By GuruFocus Research 02-12-2024

Half Year 2020 Assura PLC Earnings Presentation Transcript

By GuruFocus Research 02-12-2024

Full Year 2022 Assura PLC Investor Meeting Transcript

By GuruFocus Research 02-12-2024

Full Year 2023 Assura PLC Earnings Presentation Transcript

By GuruFocus Research 02-12-2024

Half Year 2024 Assura PLC Earnings Presentation Transcript

By GuruFocus Research 02-12-2024

Assura PLC Annual Shareholders Meeting Transcript

By GuruFocus Research 02-12-2024

Assura PLC Capital Markets Day Transcript

By GuruFocus Research 02-12-2024

Assura PLC Investor Presentation Transcript

By GuruFocus Research 02-12-2024

Full Year 2021 Assura PLC Earnings Presentation Transcript

By GuruFocus Research 02-12-2024